Neogen (NEOG) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Neogen (NEOG) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 43.57% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 26.05% |
| Feb 28, 2026 | -74.88% |
| Nov 30, 2025 | -129.20% |
| Aug 31, 2025 | -30.23% |
| May 31, 2025 | -162.37% |
| Feb 28, 2025 | -78.91% |
| Aug 31, 2024 | -80.89% |
| May 31, 2024 | 26.08% |
| Feb 29, 2024 | -81.23% |
| Nov 30, 2023 | -50.99% |
| Aug 31, 2023 | 54.35% |
| May 31, 2023 | -67.83% |
| Feb 28, 2023 | -70.95% |
| Nov 30, 2022 | -26.20% |
| Aug 31, 2022 | 21.29% |
| May 31, 2022 | 130.15% |
| May 31, 2021 | -567.78% |
| May 31, 2020 | 295.76% |
| May 31, 2019 | 11.47% |
| May 31, 2018 | -19.96% |